Compare · SLNO vs TIVC
SLNO vs TIVC
Side-by-side comparison of Soleno Therapeutics Inc. (SLNO) and Tivic Health Systems Inc. (TIVC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SLNO and TIVC operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- SLNO is the larger of the two at $2.76B, about 685.7x TIVC ($4.0M).
- TIVC has hit the wire 10 times in the past 4 weeks while SLNO has been quiet.
- SLNO has more recent analyst coverage (12 ratings vs 0 for TIVC).
- Company
- Soleno Therapeutics Inc.
- Tivic Health Systems Inc.
- Price
- -
- -
- Market cap
- $2.76B
- $4.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2014
- 2021
- News (4w)
- 0
- 10
- Recent ratings
- 12
- 0
Soleno Therapeutics Inc.
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics has collaboration with Vanderbilt University to discover and develop next generation K(ATP) channel activators for the treatment of rare diseases. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
Tivic Health Systems Inc.
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. The company's primary product, ClearUP, is a medical device intended to relieve sinus and nasal inflammation. It sells its products on direct-to-consumer channel through its own websites and platforms, such as Amazon.com, as well as to major U.S. online retailers, such as BestBuy.com, FSAStore.com, Walgreens.com, Walmart.com. The company was incorporated in 2016 and is headquartered in Newark, California.
Latest SLNO
- Amendment: SEC Form SCHEDULE 13G/A filed by Soleno Therapeutics Inc.
- Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors
- SEC Form 15-12G filed by Soleno Therapeutics Inc.
- SEC Form EFFECT filed by Soleno Therapeutics Inc.
- SEC Form POS AM filed by Soleno Therapeutics Inc.
- SEC Form AW filed by Soleno Therapeutics Inc.
- Officer Yen Kristen returned 37,639 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Volck Birgitte returned 17,536 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Sinclair Andrew returned 10,491 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Pauls Matthew returned 10,491 shares to the company, closing all direct ownership in the company (SEC Form 4)
Latest TIVC
- SEC Form 8-K filed by Tivic Health Systems Inc.
- SEC Form 8-K filed by Tivic Health Systems Inc.
- SEC Form 8-K filed by Tivic Health Systems Inc.
- SEC Form S-3 filed by Tivic Health Systems Inc.
- SEC Form 8-K filed by Tivic Health Systems Inc.
- SEC Form PRE 14A filed by Tivic Health Systems Inc.
- Tivic Health Systems Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 4 filed by Interim CEO Zikria Dean
- COO & CFO Wolf Lisa G converted options into 4 shares and covered exercise/tax liability with 2 shares, increasing direct ownership by 8% to 27 units (SEC Form 4) (withholding obligation)
- Tivic Health Systems Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits